The company made its debut last year with a $51 million Series A and a licensing agreement with Astellas for a gene therapy candidate (KT430) for X-linked myotubular myopathy. Shortly after that ...

MaxCyte, Inc. (NASDAQ: MXCT), a leading cell-engineering focused company, recently announced the acquisition of SeQure DX Inc., a market leader in on-target and off-target editing assessment services ...

Gene regulation refers to the mechanisms that act to induce or repress the expression of a gene. These include structural and chemical changes to the genetic material, binding of proteins to ...

Gene expression is the generation of a functional gene product from the information encoded by a gene, through the processes of transcription and translation. Gene products are often proteins ...

Brain Tumor Organoids Accurately Model Patient Response to CAR T Cell Therapy Dec ... 2024 — Burst sine wave electroporation was found to cause less damage to cells and tissue but more ...

This approach allows for the transient, temporal restricted expression of CARs, providing a controlled and reversible therapy (figure 2). The mRNA is typically delivered using lipid nanoparticles ...

Jan. 30, 2025 — A research group has developed new advanced light-controlled tools that enable precise control of proteins in real time in living cells. This groundbreaking research opens doors ...